From an article by Jon Markman at thestreet.com:
Using data, machine learning and AI, Alphabet managers are incubating vibrant new businesses in pharma and tech. One or more of these will become exciting stand-alone businesses.
This might seem a particularly bad time to be investing in big tech.
President Trump said Tuesday morning that his administration would look into accusations that Google has been secretly working with the Chinese military. The charge came from Peter Thiel, a PayPal (PYPL – Get Report) co-founder and strong supporter of the president.
On the other hand, Bloomberg reported Tuesday that DeepMind, the artificial-intelligence arm of Alphabet, (GOOGL – Get Report) might be on the cusp of a major breakthrough in the way new drugs are discovered.
It’s an important innovation. It’s hiding inside the search giant. And it couldn’t come at a better time.
This business is on to something really big. Using data, machine learning and AI, Alphabet managers are incubating vibrant new businesses with innovative business models. One or more of these will become exciting stand-alone businesses.
Some analysts are already doing sum-of-the-parts analyses and they like what they see.
A Jefferies analyst pegged the value of Waymo, Alphabet’s self-driving-car business, at $250 billion in December 2018, according to a story at Business Insider.
Alphabet’s market capitalization is $798 billion, with units including YouTube, Google Search, Google Cloud, Android, the Nest security camera and peripheral businesses, Google Capital, and Stadia, its new video game streaming service set to launch in November.
Together, these parts are probably worth well over $1 trillion.
Until now, the business opportunity for DeepMind was not even on investors’ radar.
The subsidiary has its roots in DeepMind Technologies, a British AI startup that was making progress teaching computers the quirks of human short-term memory. Alphabet acquired the business in 2014.
Two years later, its custom AlphaGo code was so advanced that it became the first computer program to defeat a human in a match of Go, the ancient Chinese strategy game. That human happened to be Lee Sedol, the 18-time world champion.
At the CASP13 meeting in Mexico in December 2018, DeepMind was at it again. This time its human challengers were the brightest minds in biology. The task was predicting the shapes of proteins.
Understanding these structures is important because they govern how diseases form. The problem is there are more possible protein shapes than there are atoms in the universe, Bloomberg notes.
The math has vexed computational biologists for the past 25 years. They have been trying to build more predictive software models for protein folding, the process that leads to proteins taking three-dimensional shapes.
Despite its limited experience with folding, AlphaFold, DeepMind’s entrant, predicted the most accurate structure for 25 out of 43 proteins, taking the top spot over 98 participating teams, according to a report in the Guardian.
Image Credit: Google AI
News This Week
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Leave A Comment